van den Bergh, Menno R <br/><br/>
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial.  [electronic resource] 

 -  The Pediatric infectious disease journal  Sep 2011 
 - e170-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0b013e31821a0614  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--immunology<br/>Antibodies, Viral--immunology<br/>Bacterial Proteins--immunology<br/>Carrier Proteins--immunology<br/>Diphtheria-Tetanus-Pertussis Vaccine--administration & dosage<br/>Haemophilus Vaccines--administration & dosage<br/>Humans<br/>Immunization Schedule<br/>Immunoglobulin D--immunology<br/>Infant<br/>Lipoproteins--immunology<br/>Netherlands<br/>Pneumococcal Vaccines--administration & dosage<br/>Poliovirus Vaccine, Inactivated--administration & dosage<br/>Vaccination<br/>Vaccines, Combined--administration & dosage<br/>Vaccines, Conjugate